News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
XYTOS Announces the Appointment of Farouk Dakhil, PhD as the Company’s New Chief Scientific Officer
June 22, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CARSON CITY, Nev.--(BUSINESS WIRE)--XYTOS (the "Company") (OTC: XYTS) is pleased to announce the appointment of Farouk Dakhil, PhD as the Company’s New Chief Scientific Officer and the Head of the XYTOS Scientific Advisory Board.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
C-suite
J&J, AbbVie CEOs See Pay Spike to More Than $30M
March 12, 2026
·
1 min read
·
Tristan Manalac
China
Lilly Pumps $3B Into China To Boost Supply of Weight Loss Pill
March 11, 2026
·
2 min read
·
Tristan Manalac
Podcast
Prasad Out at FDA, Lawmaker Takes Action on Rare Disease Rejections and a Spate of Obesity Data
March 11, 2026
·
1 min read
·
Heather McKenzie
C-suite
BioNTech Founders To Leave Famed mRNA Biotech for New Venture
March 10, 2026
·
2 min read
·
Annalee Armstrong